Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD Patients

(MedPage Today) -- WASHINGTON -- Treatment with the first-in-class dual phosphodiesterase 3/4 inhibitor ensifentrine reduced exacerbation rates and improved other key outcomes in patients with chronic obstructive pulmonary disease (COPD), according...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news